The EB66® cell line as a valuable cell substrate for MVA-based vaccines production

Autor: Léon, Arnaud, David, Anne-Laure, Madeline, Brice, Guianvarc’h, Laurence, Dureau, Elodie, Champion-Arnaud, Patrick, Hebben, Matthias, Huss, Thierry, Chatrenet, Benoît, Schwamborn, Klaus

Publikováno v: In Vaccine 21 November 2016 34(48):5878-5885

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome

Autor: Collaud, Fanny, Bortolussi, Giulia, Guianvarc'h, Laurence, Aronson, Sem, Bordet, Thierry, Veron, Philippe, Charles, Severine, Vidal, Patrice, Sola, Marcelo Simon, Rundwasser, Stephanie, Dufour, Delphine, Lacoste, Florence, Luc, Cyril, Wittenberghe, Laetitia, Martin, Samia, Le Bec, Christine, Bosma, Piter, Muro, Andres, Ronzitti, Giuseppe, Hebben, Matthias, Mingozzi, Federico, Guianvarc’h, Laurence

Publikováno v: Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2019, 12, pp.157-174. ⟨10.1016/j.omtm.2018.12.011⟩
Molecular Therapy-Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development, 2019, 12, pp.157-174. ⟨10.1016/j.omtm.2018.12.011⟩
Molecular Therapy. Methods & Clinical Development
Molecular therapy. Methods & clinical development, 12, 157-174. Nature Publishing Group
Molecular Therapy-Methods & Clinical Development, 2019, 12, pp.157-174. ⟨10.1016/j.omtm.2018.12.011⟩
Molecular Therapy: Methods & Clinical Development, Vol 12, Iss, Pp 157-174 (2019)

Adeno-associated viruses (AAVs) are among the most efficient vectors for liver gene therapy. Results obtained in the first hemophilia clinical trials demonstrated the long-term efficacy of this approach in humans, showing efficient targeting of hepat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15c64845ecf5191c292eb40b9a420e80
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85059833634&origin=inward

Vers l'industrialisation de la bioproduction des produits de thérapie génique.

Autor: Amsellem-Bosq, Sophie¹, Hebben, Matthias², Revah, Frédéric^1,2

Publikováno v: Biofutur. fev2017, Vol. 36 Issue 383, p37-41. 5p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.